ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

Item

http://www.wikidata.org/entity/Q33782683

Q33782683

about

Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction Lost in Translation (LiT): IUPHAR Review 6 Cardiology's 10 greatest discoveries of the 20th century Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?Article makes simple errors and could cause unnecessary deaths Chronic aspirin is effective--if data are massaged sufficiently.The effect of low-dose daily aspirin intake on survival in the Finnish centenarians cohort Current developments in anti-platelet therapy Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors The big idea: the coxib crisis iron, aspirin and heart disease risk revisited Normalization of platelet reactivity in clopidogrel-treated subjects The thrombolytic effect of aspirin in animal model Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines Cost effectiveness of ramipril treatment for cardiovascular risk reduction The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease.Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction.GPs' reasons for referral of patients with chest pain: a qualitative study.Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department.Drugs used in secondary prevention after myocardial infarction: case presentation.Global perspective on acute coronary syndrome: a burden on the young and poor.Antiplatelet medications and their indications in preventing and treating coronary thrombosis.Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINST Is the Combination of Aspirin and Clopidogrel always Better than Aspirin Alone? Or will it be too much of a good thing?Excess of mortality in patients with chest pain peaks in the first 3 days period after the incident and normalizes after 1 month.Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.The advanced practice nurse's role regarding women's delay in seeking treatment with myocardial infarction.Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials.Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areas The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income country A prospective study of long term prognosis in young myocardial infarction survivors: the prognostic value of angiography and exercise testing Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000 'Add women & stir'--the biomedical approach to cardiac research!Korean National Health Insurance value incentive program: achievements and future directions Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.Regional differences in treatment frequency and case-fatality rates in korean patients with acute myocardial infarction using the Korea national health insurance claims database: findings of a large retrospective cohort study.

P2860

Q24248081-21B5046B-43ED-4A2C-91A5-0691B545F73D Q24289150-074E7047-33D2-403A-B859-B72E2E89A3C7 Q24533369-A6F746A5-E87E-4387-88FF-955CC1C47D8C Q24605508-0A7963FB-94FD-4785-8182-AF56DEA2C0F3 Q28166614-C1BCE425-3CF4-4742-88C9-F2F58220CB43 Q28181924-9C3F5B20-D33E-48E1-ACBD-3EE393A49608 Q28192179-1BC1B01D-309A-4BF8-BE89-551282AFA202 Q28192280-EA452B4E-4541-4161-B458-602C1C8BF4DC Q28192522-968CCE0A-EAAE-47FC-B364-B3D84315ABCB Q28200685-628526EE-D8DD-429E-9161-C937A4869964 Q28210545-66FED863-A263-4EDB-8F5F-2A943B096D58 Q28217914-86A30590-B529-4EE4-8FE1-62E2D1A5686E Q28217935-6EAE5375-77D8-4E35-887F-4CCDE20EC56C Q28221834-E33F201C-65E5-42A8-A0D5-1F72BBFD644E Q28353024-FB82A8DC-01D9-4214-89DF-00DEC4494FFC Q28362658-0723178A-19CD-4617-A3DD-63B32A447026 Q30234909-6D257C09-A18D-492F-BAFC-21062A3851BB Q31053398-196CA988-9C18-4555-B822-CBCA29DE1E3D Q33438981-39CBED53-5191-44CF-9204-E62725366E05 Q33489028-760E7E6E-0207-450F-928A-8061B4832272 Q33540026-0B36CCA1-9DFF-4805-99FD-6CF48B714233 Q33689211-79318338-48F5-439A-B7A9-3FE5FD9420B1 Q33743487-36C2C7FE-8F1E-419B-8527-B35F14CB5C51 Q34078583-8F5AE7C2-E2E8-429F-95C9-309657310580 Q34088547-6D68A3AB-A359-4628-A443-ACFE7534D9E4 Q34111901-6439A5CE-B606-49DC-B1EA-1E2975AFCAAF Q34197354-E3A5F079-90CE-4511-9995-D85B30DD07B5 Q34220492-7316AC33-DFF1-4E6F-8E64-E76DBB9B34E8 Q34306450-BEDD7C96-E256-436A-BF6B-D6CCB91EB35E Q34793416-2838772B-9653-4EF7-98DB-D2802137DEA8 Q34994208-914D875B-2172-46A1-9261-9F9BE4FC6A09 Q35237334-0AE78AC5-987C-44D4-A1BC-DB4E5893F84D Q35406502-C10DA012-F07B-4F1B-839C-A7736C348726 Q35565814-FED14E3E-E9A0-4F17-863C-F58C90605D78 Q35581443-54B09C25-B1F0-4BF9-8951-E36529D27E56 Q35771589-B8E2650A-6E92-4B80-AB5A-578B03F5BA1E Q35826826-9008769C-577E-42F2-B532-E80381AA68C3 Q36031243-B4C47B81-3C38-4211-9448-3630713ECAD7 Q36094923-509EE38B-AD99-4707-9EF2-6121EC611514 Q36154124-5C0D59EB-61B5-494B-A499-11E3502AA21C

P2860

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

Item

http://www.wikidata.org/entity/Q33782683

description

1998 nî lūn-bûn

@nan

1998 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu